tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Hogy Medical Revises Dividend Policy and Ends Shareholder Benefits Amid Tender Offer Developments

Story Highlights
  • Hogy Medical will forgo dividends for the current fiscal year to ensure fairness amid a pending tender offer.
  • The company will abolish its shareholder benefit program starting in 2027 to align with its strategic plans.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Hogy Medical Revises Dividend Policy and Ends Shareholder Benefits Amid Tender Offer Developments

Claim 50% Off TipRanks Premium and Invest with Confidence

The latest announcement is out from Hogy Medical Co ( (JP:3593) ).

Hogy Medical Co., Ltd. has announced its decision to forgo dividend payments for the current fiscal year and abolish its shareholder benefit program starting from 2027, pending the successful completion of a tender offer for its shares by TCG 2509 Co., Ltd. This strategic move aligns with plans for potential delisting, ensuring fairness among shareholders, and consolidating its positioning as part of the transaction’s framework.

The most recent analyst rating on (JP:3593) stock is a Hold with a Yen5957.00 price target. To see the full list of analyst forecasts on Hogy Medical Co stock, see the JP:3593 Stock Forecast page.

More about Hogy Medical Co

Hogy Medical Co., Ltd. operates in the medical industry and specializes in producing medical products and services targeted at improving healthcare quality, with a focus on advanced technologies and market-leading solutions.

Average Trading Volume: 174,580

Technical Sentiment Signal: Buy

Current Market Cap: Yen141.9B

Find detailed analytics on 3593 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1